Predictable Medicine™
for rare disorders
Catalyzing the discovery of effective treatments for rare disease patients by finding shared mechanisms and rapidly testing using repurposed drugs and Living Molecular Twins™​
2
Clinical Trials
100+
Disorders Studied
20+
Clinical Successes
35+
Countries Reached
40,000+
Molecules
Rapid AI predictable medicine platform to help you achieve your therapeutic goals
Read our whitepapers to learn more
rareSHIFT™ has you covered
Whether you are navigating the diagnostic odyssey, complex patient populations or global clinical programs, our platform delivers end-to-end solutions. We identify new treatment avenues by screening 40,000+ molecules with >80% accuracy, enabling novel drug development and de-risking. Achieve rapid clinical trial readiness through patient stratification and uncovering hidden response subgroups and tissue-dependent mechanisms. rareSHIFT™ optimizes trials via I/E criteria, biomarkers, and longitudinal monitoring. Additional capabilities include indication expansion, cross-disease mapping, and preclinical alignment using SquishyWare™.
We transform real-time patient data into predictable results.
Discover how rareSHIFT™ can support you
Who We Work With
Our partners have a variety of different diagnoses. Hover your mouse over this interactive image to see how many patients we work with for each gene.